| MLL-r |
Mixed Lineage Leukemia-rearranged |
| ALL |
Acute lymphoblastic leukemia |
| InO |
Inotuzumab Ozogamicin |
| COG |
Children’s Oncology Group |
| MRD |
Minimal Residual disease |
| CR1 |
Clinical Remission 1 |
| CR2 |
Clinical Remission 2 |
| CR3 |
Clinical Remission 3 |
| CR4 |
Clinical Remission 4 |
| CR5 |
Clinical Remission 5 |
| CAR-T |
Chimeric Antigen Receptor – T Cell |
| CNS |
Central Nervous System |
| CT |
Computerized Tomography |
| ANC |
Absolute Neutrophil Count |
| PTT |
Partial Thromboplastin Time |
| VOD |
Vaso Occlusive Disease |
| AST |
Aspartate Transaminase |
| ALT |
Alanine Transaminase |
| GGT |
Gamma Glutamyl Transferase |
| BID |
Two times a day |